Literature DB >> 7007509

The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus.

R Smeenk, L Aarden.   

Abstract

With a recently introduced method for measurement of low-avidity anti-DNA, the polyethylene glycol (PEG) precipitation assay (Riley et al., 1979), high levels of DNA binding by normal human serum (NHS) were found when circular PM2-DNA was used as antigen. THe nature of this DNA binding was studied. The removal of low-density lipoproteins (LDL) from the serum, e.g., by Aerosil absorption, eliminated DNA binding by NHS. Purified LDL bound DNA to the same extent as NHS. Non-specific binding of NHS or LDL to DNA was prevented by adding dextran sulphate to the incubation mixture. Analysis on sucrose gradients showed that only large DNA-anti-DNA complexes were precipitated by 3.5% PEG. The PEG assay with dextran sulphate is a sensitive assay for low-avidity anti-DNA antibodies. It adds important information to results obtained with the Farr assay, which mainly detects antibodies of high avidity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007509     DOI: 10.1016/0022-1759(80)90305-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

1.  LDL-mediated interaction of DNA and DNA-anti-DNA immune complexes with cell surface.

Authors:  A E Kabakov; V A Saenko; A M Poverenny
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

2.  Relation between serological data at the time of biopsy and renal histology in lupus nephritis.

Authors:  J C Nossent; S C Henzen-Logmans; T M Vroom; V Huysen; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 3.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

Review 4.  Systemic diseases and the detection of antinuclear and anticytoplasmic antibodies. An historical review.

Authors:  M Walravens
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

5.  Measurement of serum DNA binding in chronic active hepatitis and systemic lupus erythematosus using the Farr assay.

Authors:  K M Pollard; R Steele; S Hogg; J Webb
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

6.  Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.

Authors:  C C Erhardt; P Mumford; R N Maini
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

7.  Prognostic value of anti-dsDNA in SLE.

Authors:  A J Swaak; J Groenwold; L A Aarden; L W Statius van Eps; E W Feltkamp
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

8.  Monoclonal human anti-DNA antibodies from EB virus-transformed lymphocytes of systemic lupus erythematosus (SLE) patients.

Authors:  T Sasaki; T Muryoi; Y Sekiguchi; E Tamate; K Yoshinaga; Y Kitagawa
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

9.  Detection of antibodies to DNA: a technical assessment.

Authors:  R Smeenk; M Hylkema
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

Review 10.  Anti-dsDNA: choice of assay in relation to clinical value.

Authors:  R J Smeenk; H G van den Brink; K Brinkman; R M Termaat; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.